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Changes in collagenases and TGF-b precede structural alter- In recent years, investigators studying the mechanisms
ations in a model of chronic renal fibrosis. of progressive renal disease have increasingly empha-
Background. To study the role of collagenases and trans- sized the role of the interstitial changes. From early re-
forming growth factor-b (TGF-b) in the genesis of interstitial
ports stressing clinicopathological correlations betweenfibrosis, we used the model of bromoethylamine (BEA)-induced
the degree of interstitial disease and the loss of renalpapillary necrosis, which is known to lead over a period of 1
to 12 months to interstitial fibrosis and renal insufficiency. function, emphasis has shifted to studies of the mecha-
Methods. Rats were injected with BEA, and urine and kid- nisms by which fibrosis may occur, in glomerulonephritis
ney tissue (cortex and medulla) were collected after 1, 2, 3, 7, as well as in processes that begin in the interstitium,
and 30 days. One kidney was perfused and fixed for morpholog-
renal medulla, or papilla [1]. In the experimental modelical studies and immunostained for collagen type I, III, and
of bromoethylamine (BEA)-induced papillary necrosis,IV. The other kidney was used to prepare cortex and medulla
the lesion is produced by a single injection of the drug.extracts for gelatinases (by fluorometric and zymographic tech-
niques), tissue inhibitors of metalloproteinase-1 (TIMP-1), and Previously, we have described the functional characteris-
TIMP-2 (by enzyme-linked immunosorbent assay, ELISA) and tics of this lesion at three days and showed that it is
TGF-b1 (by ELISA). associated with a profound defect in urinary concentra-
Results. Albuminuria and interstitial fibrosis were present
tion, a modest decrease in the glomerular filtration ratein BEA rats by day 7, which continued until day 30. Immunocy-
(GFR), and an impaired ability to conserve sodium andtochemical staining for collagen types showed that collagen III
excrete a potassium load [2]. More recently, we observedand IV increased in the interstitium by day 30, but collagen I
remained unchanged. Gelatinase activity in the medulla de- albuminuria at one week, the mechanism of which is
creased by 57% compared with control by day 2 and remained unknown, and the presence of ED-1–positive cells in the
low until day 30. In the cortex, gelatinase activity remained interstitium suggestive of monocytic/macrophage infil-unchanged between 0 and 7 days after BEA but decreased by
tration at one-month post-BEA [3, 4]. These early func-72% by day 30. TIMP-1 and TIMP-2 were decreased by 80%
tional changes are followed in the ensuing months bycompared with day 0 in both the medulla (by day 1) and cortex
(by day 2) and remained low up to day 30. TGF-b1 immunore- nephrotic-range proteinuria and eventually by irrevers-
activity increased progressively until day 2 in the medulla (16- ible loss of renal function associated histologically with
fold higher than control) and day 3 in the cortex (8-fold higher focal glomerular sclerosis and extensive interstitial fi-
than control) and returned to control level by day 3 in the brosis [3–5]. Such fibrosis is characterized by the deposi-medulla and by day 30 in the cortex. Two days after BEA
tion of collagen, a group of large proteins that is synthe-injection, the mRNA for TGF-b1 was increased eightfold in
sized and degraded by a complex but finely regulatedthe cortex and 12-fold in the medulla, and it remained high
for up to 30 days. mechanism [6].
Conclusions. The fibrosis that follows papillary necrosis is The degradation of matrix including collagen takes
associated with both high TGF-b1 expression and depressed place through the action of collagenases (including gela-
gelatinolytic activity.
tinases) in a process subject to fine regulation by many
factors, including peptide inhibitors of collagenases
called tissue inhibitors of metalloproteinases (TIMPs)Key words: transforming growth factor b, bromoethylamine, interstitial
fibrosis, collagenases, gelatinses, TIMP, papillary necrosis. [7, 8]. Also modulating fibrosis is transforming growth
factor-b1 (TGF-b1), a paracrine cytokine that acts byReceived for publication June 26, 1998
increasing the synthesis of matrix molecules and by de-and in revised form February 15, 1999
Accepted for publication February 26, 1999 creasing their degradation [9]. To further understand the
role of these factors, collagenases, TIMPs, and TGF-b1 1999 by the International Society of Nephrology
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Table 1. Renal function after a single injection of BEA in rats were separately collected into guanidinium isothiocya-
nate solution (4 m guanidinium isothiocyanate, 25 mmCCr Urine albumin
ml /min /100g body weight mg/24 hrs Na citrate, 0.5% Sarcosyl, 0.1 m 1-mercaptoethanol) and
homogenized for RNA extraction. The cortex and me-Control 0.7160.07 2.87 61.08
BEA day 7 0.41 60.04a 34.368.1a dulla from another kidney were collected separately in
BEA day 30 0.37 60.04a 23.861.8a cold 100 mm Tris-HCl buffer pH including 1 mm calcium
N 5 7 for each group. chloride, homogenized, and sonicated for 20 secondsa P , 0.05 compared to control
each, centrifuged at 3000 r.p.m. for 20 minutes, and
stored at 2208C after adding 1/10 volume of 1% of Tri-
ton-100 (final 0.1% Triton) for gelatinase and TGF-b1
assay. Protein was measured in the final tissue extract byin renal scarring, we have studied their expression in
the Bio-Rad method (Bio-Rad Laboratories, Richmondan experimental model of renal papillary necrosis, and
CA, USA).found that over a period of 1 to 12 months their expres-
sion leads to chronic interstitial and glomerular fibrosis.
Gelatinase assay
Tissue extracts were adjusted to 0.5 mg/ml protein,
METHODS and gelatinase was quantitated by a fluorescence assay
using gelatin FITC as the substrate as described pre-Papillary fibrosis model
viously [10]. After one hour of incubation of extracts atAdult male Sprague-Dawley rats (Harlan, Indianapo-
378C with the substrate, the release of free fluoresceinlis, IN, USA) weighing 300 to 325 g were given a single
was measured at Ex 490 and Em 519. As a standard,50 mg intraperitoneal injection of BEA (Sigma Chemical
bacterial collagenase (25 mg; Sigma) was added to aCo., St. Louis, MO, USA) [4]. The same volume of saline
separate tube to degrade the gelatin substrate com-was given to the control animals. Water and food were
pletely. In preliminary experiments, plasmin was addedprovided ad libitum.
to the test samples to activate latent gelatinases, but theCreatinine clearance and urinary albumin excretion
activity remained unchanged, suggesting a spontaneouswere determined in all animals on the day of sacrifice,
activation in our extracts. Therefore, it was not used foras previously described [4].
this study. Gelatinase activity, as measured by this assay,
is expected to yield the net gelatinolytic activity, that is,Tissue processing for histology and
only that available activity that is free of TIMP inhibition.immunocytochemical studies
Urinary gelatinase activity was similarly assayed in
Seven and 30 days after BEA injection, the rats were dialyzed and 310 concentrated urine specimens. The
anesthetized with sodium pentobarbitol (35 mg/kg), and activities were converted to 24-hour excretion values by
their kidneys were briefly perfused retrogradely with normalizing to 1 g of creatinine.
cold phosphate (10 mm)-buffered saline (PBS; NaCl 125
mm), pH 7.4, to remove blood. Following this, 50 ml of Zymography
HistoChoice fixative (Amresco Inc., Solon, OH, USA) Fifty micrograms of sample protein were subjected to
were perfused over a period of one minute, and finally, sodium dodecyl sulfate-polyacrylamide gel electropho-
the kidneys were washed by perfusing cold PBS. For resis (SDS-PAGE) in 8% polyacrylamide gel impreg-
morphological studies, kidneys were postfixed by immer- nated with 1 mg/ml of twice-crystallized gelatin as de-
sion in HistoChoice fixative for several days. Blocks of scribed in detail previously [10]. After electrophoresis,
kidneys were processed for paraffin embedding. Sections gels were washed in buffer containing 1% Triton-100 to
(10 mm thick) were stained with Trichrome (for morpho- displace SDS, and gels were developed in 100 mm Tris
logical studies) and were immunostained for collagen I, buffer containing 5 mm CaCl2 and 1 mm ZnCl2. Gels were
III, and IV using respective primary antibodies (South- then stained with Coomassie Brilliant Blue R (Sigma)
ern Biotechnology, Birmingham, AL, USA) and alkaline and destained. Gelatinases appeared as clear bands on
phosphatase-conjugated second antibodies followed by a blue background. Conditioned mesangial cell media
a development reaction as indicated by the manufacturer containing the 72 and 92 kDa gelatinases were used as
(Sigma). standard [10, 11].
Tissue processing for RNA and enzyme studies Enzyme-linked immunosorbent assay for tissue
inhibitors of metalloproteinase-1, tissue inhibitorsOne, 2, 3, 7, and 30 days after BEA injection, rats
of metalloproteinase-2, and transformingwere anesthetized with sodium pentobarbitol (35 mg/
growth factor-b1kg), and their kidneys were briefly perfused with cold
PBS to remove blood as described earlier here. One Samples for TIMP assay were adjusted to 0.8 mg/ml
in protein. TIMP-1 and -2 assays were performed usingkidney was quickly excised, and the cortex and medulla
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enzyme-linked immunosorbent assay (ELISA) kits from 1 m NaCl, 10 mm NaH2PO4, 5 3 Denhardt solution, 1%
SDS, and 250 mg/ml salmon sperm DNA at 428C for fourBiotrak (Amersham Pharmacia Biotech, Buckingham-
shire, UK). The kits included microtiter wells precoated hours followed by hybridization in the same buffer with
2 3 106 cpm/ml of a 32P-labeled cDNA probe for humanwith the primary anti–TIMP-1 (or anti–TIMP-2) anti-
bodies. Assay samples were incubated in the wells, fol- TGF-b1 (American Type Culture Collection, Bethesda,
MD, USA), and incubated at 428C overnight. Afterlowing which they were washed and finally detected with
the secondary anti–TIMP-1 (or anti–TIMP-2) antibody washing in 2 3 SSC (0.15 m NaCl, 0.015 m Na citrate),
0.1% SDS three times followed by two washes in 1 3conjugated to peroxidase. The peroxidase conjugate was
developed by the enzyme substrate solution containing SSC with 1% SDS for 20 minutes at 508C, the membrane
was subsequently exposed to x-ray film at 2708C fortetramethyllbenzidine/hydrogen peroxide. Absorbance
was read at 450 nm using a microplate reader (Molecular 72 hours. The results were standardized to equal RNA
loading by the density of the corresponding 18s rRNADevices Corporation, Sunnyvale, CA, USA). Standards
of purified TIMP-1 (or TIMP-2) were included in the of each sample as described previously [10].
assay.
Statistical analysesA sandwich ELISA was used for TGF-b1 assay ac-
cording to the manufacturer’s instructions (R&D Sys- All results were analyzed parametrically using stan-
dard t-statistics, which include computation of means,tems, Minneapolis, MN, USA). Briefly, vinyl microtiter
plates (Costar, Cambridge, MA, USA) were coated with sem, and significance by P values. Results are presented
as means 6 sem. P values of less than 0.05 were consid-100 ml of 4 mg/ml monoclonal mouse anti–TGF-b1 in
PBS at 48C overnight. Following three washes with wash- ered as significant and are indicated in the figure legends.
ing buffer (0.5% Tween-20 in PBS), the tissue extracts
preadjusted to 1.5 mg/ml in protein were added to dupli-
RESULTS
cate wells and incubated at room temperature overnight.
Functional and structural changes in the kidneyThe wells were washed, and 100 ng/ml of rabbit anti-
following bromoethylamine injectionmouse biotinylated anti–TGF-b1 were added. The plates
were incubated for one hour at room temperature. Strep- Following a single injection of BEA, the renal func-
tional impairment was the first sign of the onset of diseasetavidin-horseradish peroxidase (1:1000 dilution; Zymed
Labotories, Inc., San Francisco, CA, USA) was added (Table 1). Creatinine clearance was reduced by 42% at
day 7 and 48% at day 30. Albuminuria increased 12-foldas the detection reagent. Finally, the reaction was devel-
oped by the substrate (1 mg/ml of o-phenylenediamine by day 7 and recovered partially by day 30.
Mild structural changes in the kidney were apparentdihydrochloride, 0.8 ml/ml of 30% H2O2). Absorbance
was read at 450 nm in a microplate reader. The concen- at day 7 (picture not shown), which became pronounced
by day 30 (Fig. 1). The changes were most remarkabletration of TGF-b1 was determined from the standard
curve in the range of 10 to 1000 pg/ml. This activity in the medulla, where blue staining collagen accumulated
diffusely in the interstitium, resulting in the widening ofrepresented active TGF-b1.
The assay was repeated after activation of samples by the intertubular space. In a few areas, tubular atrophy
was seen. The intertubular space also contained a cellularacidification (with 1 m HCl), incubation for 10 minutes,
and finally neutralization with 1.2 m NaOH/0.5 m HEPES. infiltrate consisting of mononuclear cells. Similar changes
were visible in the cortex, but only in focal areas (notThe protein concentration was adjusted to 1.5 mg/ml for
assay as before. The activity obtained after activation shown).
Immunoenzymatic staining for collagens I, III, and IVrepresented the total activity. Latent activity was derived
as total activity–active (preactivated). showed that collagens III and IV accumulated in the
medullary interstitium at day 30 in an identical manner
RNA extraction and Northern blot analysis (only collagen IV staining is shown in Fig. 2). No changes
were observed in the distribution of collagen I (data notTotal RNA was extracted by phenol:chloroform:iso-
amyl alcohol and precipitated by isopropanol (Molecular shown). These changes in collagen distribution were not
seen at day 7 (data not shown). Similar, although lessBiology grade; Sigma) The concentration of RNA was
measured at 260 nm, and samples were stored at 2208C remarkable, changes were seen in the cortex at day 30
(data not shown).until use. For Northern blotting, 20 mg of total RNA
were electrophoresed in 1.1% agarose gel containing
Gelatinase activity in the cortex, medulla and urine of5% formaldehyde. The gels were blotted onto Nytran
bromoethylamine ratsmembranes (Schleicher and Schuell, Inc., Keene, NH,
USA) by upward capillary flow and were immobilized Gelatinase activity, an important regulator of collagen
accumulation, was measured in extracts of medulla andby baking the membrane for two hours at 808C. The
membranes were then prehybridized in 50% formamide, cortex at days 0, 1, 2, 3, 7, and 30 after BEA injection.
Fig. 1. Morphology of the cortico-medullary
region of a rat kidney 30 days after injection
with bromoethylamine (BEA; trichrome stain-
ing magnification 3200). The medulla is filled
with interstitial fibrous material (blue staining)
and cellular infiltrate of mononuclear cells.
Smaller areas of fibrogenesis were also visible
in the cortical region (data not shown).
Fig. 2. Immunoenzymatic staining for collagen
IV in the medulla of rats 30 days after a single
injection of bromoethylamine (BEA; A, con-
trol; B, BEA injected; magnification 3300).
There was an accumulation of collagen IV in
the basal lamina of the tubular structures in the
medullary region after BEA injection. Identical
changes were observed for collagen III (data not
shown). No changes were seen in the collagen I
distribution (data not shown).
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though the magnitude of the increase varied throughout
the observation period (Fig. 5). The increase in urinary
gelatinases was associated with a corresponding decrease
in gelatinase activity in the medulla. By zymography,
gelatinase activity in control rat urine was also present
in the 72 and 92 kDa forms (Fig. 6). Following BEA
injection, both forms of the enzyme increased, and a new
150 kDa form appeared in the urine.
Tissue inhibitors of metalloproteinase-1 and -2
immunoreactivity in the cortex and medulla of
bromoethylamine rats
Tissue inhibitors of metalloproteinase-1 and -2 were
measured in tissue extracts at days 0, 1, 2, 3, 7, and 30
after BEA injection. In the cortex, both TIMP-1 and
-2 were detectable at all time points. The basal (day 0)
immunoreactivity of TIMP-2 was 300 times higher than
that of TIMP-1. After BEA injection, both TIMP-1 and -2
were decreased by more than 80% by day 2 and remained
at that level up to day 30 (Fig. 7, upper panel). In the
medulla, the basal (day 0) TIMP-1 level was also much
lower than the level of TIMP-2. After BEA injection,
there was a rapid decrease of TIMP-1 and TIMP-2 by
80% by day 1 and remaining low for up to day 30 (Fig.
7, lower panel).
Transforming growth factor-b1 levels and
mRNA in the cortex and medulla after
bromoethylamine injection
Transforming growth factor-b1, a cytokine critical in
Fig. 3. Gelatinase activity in cortex (A) and medulla (B) between days the signaling matrix production in renal tissue, was mea-
0 to 30 following a single injection of bromoethylamine (BEA) in rats. sured by ELISA in extracts of cortex and medulla at
Data are presented as means with limit bars showing standard errors.
different times (0 to 30 days) following BEA injectionThe number of animals at each point are day 0 (control) 5 4; day 1 5
4; day 3 5 6; day 7 5 8; day 30 5 8. The asterisks denotes statistical (Fig. 8 A, B). It was noted that although in the cortex
significance compared with day 0 at P , 0.05. No remarkable changes all TFG-b1 activity was present in the active form and
in gelatinase activity were observed in the cortex between days 1 to 7,
none in the latent form, it was the opposite in the me-but there was a 72% decrease of gelatinase activity by day 30. In the
medulla, there was a 57% decrease of activity by day 2, followed by a dulla, wherein most activity was in the latent form and
partial recovery by day 7, which persisted up to day 30. very little in the active form. Cortical levels of active
TGF-b1 were increased sharply above control levels
(eightfold) between days 3 to 7, with a drop to control
levels by day 30 (Fig. 8A). In the medulla, the level ofNo significant differences were observed in the cortex
latent TGF-b1 increased 14-fold by day 1, reaching aup to day 7, but gelatinase activity was decreased at day
peak level by day 2 (16-fold). The levels recovered be-30 by 72% (Fig. 3A). In the medulla, there was a rapid
tween days 3 to 30 but tended to be higher than controlsdecrease of activity by 57% at day 2, and the activity
(Fig. 8B).remained depressed throughout the observation period
Changes in messenger RNA levels of TGF-b1 pre-(Fig. 3B).
ceded the activity changes in the cortex (Fig. 9, upperZymographic analyses of these extracts revealed bands
panel). Densitometric analyses of the autoradiographsof 72, 92, and 150 kDa gelatinases in the medulla and
normalized against 18s rRNA on blots showed that incortex (Fig. 4A, B). In the cortex, no remarkable changes
the cortex there was an eightfold increase in message atwere observed in the band pattern between days 0 to
day 2 that recovered to threefold at days 7 and 30 (all30. In contrast, medulla showed a progressive decrease
comparisons are to day 0, control levels; Table 2). Thein intensity of one or all three forms of gelatinase activity
changes in medulla were more remarkable: a 12-foldat the time points studied, becoming minimal by day 30.
increase at days 2 to 3, followed by a recovery to eightfoldUrine gelatinase activity was uniformly higher follow-
ing BEA injection compared with control values, al- at days 7 to 30 (Fig. 9, lower panel, and Table 2).
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Fig. 4. Zymography of cortical (A) and medullary (B) tissue samples at days 0 to 30 after bromoethylamine (BEA) injection. The lanes are A,
control; B, day 1; C, day 2; D, day 3; E, day 7; F, day 30. Both tissues contained 72, 92, and 150 kDa forms of gelatinases (shown as marks on the
left margin). No remarkable changes were observed in the cortex until day 30 (upper panel). In contrast, the medulla showed a decrease in intensity
of one or all forms of gelatinase activity at the time points studied, becoming minimal by day 30. Please note that the black/white contrast has
been reversed.
Fig. 6. Zymography of rat urines following a bromoethylamine (BEA)
injection. The lanes are a, control; b, day 1; c, day 2; d, day 3; e, dayFig. 5. Gelatinase excretion in urine of rats injected with bromoethy-
7; f, day 30. The positions of 72, 92, and 150 kDa are shown as markslamine (BEA). Data are presented as means with limit bars showing
on the left margin. Gelatinase activity in control rat urine was presentstandard errors. The numbers of animals at each time point are indicated
in the 72 and 92 kDa molecular forms. Following BEA injection, therein the bars. The asterisk denotes statistical significance compared with
was increase in both forms of the enzyme, and a new 150 kDa form ofday 0 at P , 0.05. Urine gelatinase activity was uniformly high following
gelatinase appeared. Please note that the black/white contrast has beenBEA injection.
reversed.
DISCUSSION
interact to make the matrix functional [13, 14]. Of theIn this model of papillary necrosis and interstitial fi-
18 different types of collagen [12], it is known that at leastbrosis, we studied some of the factors critical in the laying
collagen I, III, and IV are deposited in the interstitium indown of fibrous tissue, a complex process that involves
fibrosing renal diseases [1, 15].enzymes, their inhibitors, and cytokines [1]. Collagen is
At any point, the tissue concentration of collagen de-the most important of the proteins, but laminin, fibro-
pends on the balance between its synthesis and degrada-nectin, entactin (nidogen), and proteoglycans also play
tion [6]. Degradation is regulated by matrix metalloprotein-a part, distributed in different proportions at different
ase (MMP) enzymes, such as the interstitial collagenases,sites [12]. The macromolecular organization of the fi-
stromelysins, and type IV collagenases (gelatinases), allbrous tissue is complex and is best exemplified by the
lacking strict substrate specificity and demonstratingbasement membrane in which the collagen forms the
scaffolding on to which other matrix proteins bind and overlapping reactivities towards various matrix mole-
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Fig. 7. Immunoreactivity of TIMP-1 and TIMP-2 in cortex and medulla
of bromoethylamine (BEA) rats. Data are presented as means with
limit bars showing standard errors. The numbers of animals at each
point are day 0 (control), 5; days 1 to 30, 4. The asterisk denotes
Fig. 8. Immunoreactivity of transforming growth factor-b1 (TGF-b1)statistical significance compared with day 0 at a P , 0.05. Note that
levels in cortex (A) and medulla (B) after bromoethylamine (BEA)TIMP-2 levels are several-fold higher than TIMP-1 levels. In the cortex,
injection. Data are presented as means with limit bars showing standardfollowing BEA injection, both TIMP-1 and TIMP-2 were decreased by
errors. The numbers of animals at each point are day 0 (control), 4;more than 80% by day 2 and remained at that level for up to day 30.
day 1, 4; day 3, 6; day 7, 8; and day 30, 8. The asterisk denotes statisticalIn the medulla, there was a more rapid decrease of TIMP-1 and -2 by
significance compared with day 0 at a P , 0.05. Cortical levels of active80% by day 1 and remained low for up to day 30.
TGF-b1 increased eightfold between days 3 to 7, falling to control levels
by day 30. In contrast, latent TGF-b1 levels increased 14- to 16-fold by
days 1 and 2 in the medulla. The levels recovered between days 3 to
30 but remained higher than controls.
cules [7, 16, 17]. Gelatinase A and B (also known as
MMP-2 and MMP-9) degrade collagen type IV and gela-
tin, as well as other collagen types, and are synthesized graphically and quantitatively, a finding comparable to
as proenzymes that must then be activated by proteolytic that of Ricardo et al in the unilateral ureteral obstruction
cleavage [17]. These two gelatinases are regulated by model, where meprin (a collagenolytic enzyme) de-
TIMP-1 and TIMP-2 as they bind to form inactive com- creased after 12 hours of injury [21]. It is notable that
plexes: TIMP-1 with gelatinase B and TIMP-2 with gela- whereas in other studies of chronic renal injury a de-
tinase A [8]. These two gelatinases and their inhibitors crease in collagenase activity was inferred from the find-
have been shown to be present in kidney cells [18–20]. ing of increased inhibitors [22, 23], in our study, it was
Also, they can be measured easily and accurately and shown to be due to a decrease in the enzyme activity
are relevant to our study because the collagen that accu- inferred from activity assays and the zymograms. It must
mulates in the interstitium was shown in this study to be emphasized that our collagenase activity assay yields
be of type III and IV. We found that at 24 hours after the overall collagenolytic activity, over and above that
induction of papillary necrosis, the activity of the two inhibited by TIMPs. Surprisingly, both TIMP-1 and
TIMP-2 were also decreased in the cortex and medullagelatinases was decreased in the medulla, both zymo-
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Table 2. Intensity of TGF-b1 bands on the Northern blots
Day
0 1 2 3 7 30
Cortex 1 1.05 8.06 8.16 2.93 3.01
Medulla 1 0.34 13.08 12.08 7.35 9.92
Numbers are arbitrary density units obtained by normalizing individual bands
to their respective 18s bands on the Northern blots (not shown) and comparing
with control (day 0), which was set as 1.
which TGF-b1 is the best studied [28]; (c) is secreted in
an inactive form and converted to an active form by
unknown mechanisms [29]; and (d) though known to
increase matrix synthesis was also recently shown to de-
crease collagenase activity (abstract; Song et al, J Am
Fig. 9. mRNA levels for TGF-b1 by Northern blotting in cortex (upper
Soc Nephrol 4:972A, 1994). In our studies, TGF-b1 im-panel ) and medulla (lower panel ) following bromoethylamine (BEA)
injection. Densitometric analyses of the band intensities normalized munoreactivity increased significantly within one to two
against 18s RNA and compared with control set at 1 (Table 2). An days in the medulla and within three to seven days in
eightfold increase in TGF-b1 message occurred in the cortex at day 2,
the cortex, followed by a decrease to normal levels atwhich recovered at later time points but remained threefold higher
later time points. These transient though dramaticlevel until day 30. In the medulla, the TGF-b1 message increased 12-
fold between days 2 and 3 following BEA injection, followed by a changes in TGF-b1 are distinguishable from other
recovery to eightfold between days 7 to 30. chronic models of unilateral ureteral obstruction [30,
31], protein overload [22], and cyclosporine [32], where
increases in TGF-b1 were of lesser magnitude but were
sustained for weeks after the initial injury. Such increasesby 80% within days 1 and 2 and remained reduced
noted by other investigators in other chronic modelsthrough day 30. In other models of interstitial fibrosis,
were obtained from mRNA levels and not from immuno-TIMP-1 activity was increased [22–24], suggesting a role
reactivity studies. In our study, the increase in mRNAin decreasing net collagenolytic activity, thus contribut-
TGF-b1 levels was also sustained for a longer time (uping to fibrosis. The reason for the discrepancy between
to 30 days). This discrepancy between immunoreactivityour results and those of other investigators is not com-
and message levels may be suggestive of a mechanismpletely clear. It should be noted, however, that the major-
at the tissue level that can modulate the TGF-b1 levelity of these studies only measured TIMP activity to infer
independent of mRNA. Possible local mechanisms maynet collagenolytic activity. Thus, the contribution of col-
be at the level of conversion of latent protein-bound
lagenase itself and TIMPs by themselves and net colla-
inactive TGF-b1 to free TGF-b1 [33] or the release of
genolytic activity has not been addressed in the same matrix-bound TGF-b1 [34].
study. Nonetheless, the reduced TIMP levels we ob- It is of note that changes in gelatinase and TGF-b1
served probably reflected an attempt by the tissue to occurred first in the medulla and subsequently in the
increase collagenolytic activity, which was overridden by cortex. This is consistent with the pattern of the morpho-
a greater decrease in the gelatinase levels. logical injury in the BEA model, in which the injury
We also found that urinary gelatinases increased dur- originates from the papilla and radiates toward the cor-
ing the first three days, coinciding in time with the de- tex [4]. The rise of TGF-b1 and decrease of gelatinase
crease in tissue medullary levels of the enzyme. We do activity within the first few days of BEA injection, much
not believe, however, that a urinary loss of gelatinases before structural and functional changes are observed,
contributed to the decrease in tissue levels or that the is indicative of an early metabolic disturbance encom-
increase in urinary gelatinases was related to the BEA- passing the entire renal parenchyma. The decrease in
induced diuresis, because causing a water diuresis with gelatinase activity and an increase in TGF-b1 may be
sucrose did not increase urinary gelatinases excretion the earliest events in the cascade of reactions leading to
(unpublished results). The early increase in urinary colla- renal fibrosis.
genases may simply be a reflection of cell damage alter-
Reprint requests to Ashok K. Singh, Ph.D., Hektoen Institute foring the polarity of gelatinases secretion.
Medical Research, 627 South Wood Street, Chicago, Illinois 60612, USA.
Also playing a role in the deposition of fibrous tissue E-mail: singashok@aol.com
is TGF-b1, an important regulator of matrix accumula-
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